A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Jan, 5 2025
Dec, 7 2024
Oct, 3 2024
Jul, 7 2025
Nov, 18 2025